Publication | Closed Access
F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity
35
Citations
23
References
2013
Year
Tumor BiologyMedicinePharmacologyClinical TrialsPolyamine-vectorized Anti-cancer DrugPharmacotherapyAnti-cancer AgentCancer TreatmentDrug DevelopmentOncologyRadiation OncologyCancer ResearchDrug DiscoveryHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1